Class II recall: Golden State Medical Supply Inc.: Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-2
Golden State Medical Supply Inc. has initiated a Class II recall of Carbamazepine Tablets, USP, 200mg, distributed in 1000-count and 100-count bottles (NDC 51407-215-10 and 51407-215-01), manufactured by Taro Pharmaceutical Industries Ltd. The recall was prompted by CGMP deviations, specifically tablets found to contain black specks.
Most relevant for: Patients currently prescribed carbamazepine 200mg tablets from these specific lots for seizure or other neurologic indications.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More neurology updates
- Intensive BP Lowering Benefits Deep but Not Lobar HemorrhageNov 10, 2026
- Earlier Blood Biomarker Disclosure Boosts Diagnostic Certainty in Memory ClinicOct 5, 2026
- Iatrogenic cerebral amyloid angiopathy linked to high recurrent hemorrhage riskOct 27, 2026
- Study identifies clinical risk factors for chemotherapy-induced nerve toxicityOct 27, 2026
- Cervical cord atrophy in MS exceeds normal age-related declineOct 27, 2026